Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 1188

DECLARATION re #1187 MOTION in Limine Defendants' Motion In Limine to Preclude Amgen From Presenting Testimony of Charles Kung (by Peter Fratangelo) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Fleming, Thomas)

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 1188

Case 1:05-cv-12237-WGY

Document 1188

Filed 09/28/2007

Page 1 of 2

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS AMGEN INC., Plaintiff, vs. F. HOFFMANN-LA ROCHE, LTD; ROCHE DIAGNOSTICS GmbH; and HOFFMANN-LA ROCHE INC. Defendants. ) ) ) ) ) ) ) ) ) ) ) ) )

CIVIL ACTION No.: 05-CV-12237WGY

DECLARATION OF PETER FRATANGELO IN SUPPORT OF DEFENDANTS' MOTION IN LIMINE TO PRECLUDE AMGEN FROM PRESENTING TESTIMONY OF CHARLES KUNG I, Peter Fratangelo, declare under penalty of perjury that: 1. I am an attorney admitted to the Bars of the Commonwealth of Massachusetts and

the State of New York and this Court. I am an associate at the law firm of Kaye Scholer LLP, counsel for Defendants in the above-referenced case. 2. I make this declaration in support of Defendants' Motion in Limine to Preclude

Amgen from Presenting Testimony of Charles Kung. 3. Exhibit A is a true and correct copy of First Letter from Renee DuBord Brown to

Tom Fleming, dated September 27, 2007. 5. Exhibit B is a true and correct copy of Second Letter from Renee DuBord Brown

to Tom Fleming, dated September 27, 2007.

Dockets.Justia.com

Case 1:05-cv-12237-WGY

Document 1188

Filed 09/28/2007

Page 2 of 2

6.

Exhibit C is a true and correct copy of an email chain containing an email from

Thomas Fleming to Renee DuBord Brown dated Sept. 26, 2007 at 6:07pm, and response from Ms. Brown to Mr. Fleming on Sept. 27, 2007 at 1:04pm. Dated: September 27, 2007 Boston, Massachusetts

/s/ Peter Fratangelo Peter Fratangelo

CERTIFICATE OF SERVICE I hereby certify that this document filed through the ECF system will be sent electronically to the registered participants as identified on the Notice of Electronic Filing (NEF) on the above date.

/s/ Thomas F. Fleming Thomas F. Fleming

2